Bluefish Pharmaceuticals
Louise Danielsson is an experienced sales and supply chain professional with a robust background in pharmaceuticals and logistics. Currently serving as Sales Manager at Bluefish Pharmaceuticals since July 2022, Louise previously held roles at Accord Healthcare, including Inventory Controller for the Nordics & Baltics and Logistics Coordinator, where responsibilities included managing forecasts and controlling product flow. Earlier career experiences include positions at Meda AB as an Accountant focusing on finance and supply planning, as well as roles in demand planning and logistics with Johnson & Johnson and MEDA. Louise's career began in trade accounting with Wallenius Wilhelmsen Logistics and LauritzenCool, where expertise in freight and trade analysis was developed. Education credentials include attendance at Midhurst Grammar and various institutes related to purchasing and shipbroking.
This person is not in any offices
Bluefish Pharmaceuticals
Founded in Sweden, with its long tradition of industrial entrepreneurship, Bluefish Pharmaceuticals has become one of the most progressive generics pharmaceuticals companies. At Bluefish, we strive to make quality medicines accessible to more people. We create value in the full pharmaceutical value chain from developing to manufacturing and successfully marketing generic pharmaceuticals and we take pride in doing this in an innovative, responsible and cost-efficient way. Bluefish currently conducts operations in 19 countries in Europe and, over the next few years, will also expand outside Europe with the aim of becoming a global player. Our corporate culture and close collaboration with development and manufacturing partners are integral parts of our effort to deliver quality products at affordable prices. We offer a product portfolio consisting of a broad range of high quality generics for all major therapeutic areas. It is part of our long-term strategy to expand the product portfolio of off-patent blockbusters while at the same time offering a broader range of niche products within more narrow disease areas.